PacBio (NASDAQ: PACB) announced on August 5, 2026 that SPRQ-Nx chemistry will raise per-run HiFi output on its Vega benchtop sequencer from 60 Gb to 90 Gb, per the company's press release.
GenScript Biotech Corporation and Tamarind Bio announced a strategic partnership on August 5, 2026, connecting Tamarind's AI-powered molecular design platform with GenScript's wet-lab validation services.
US bioeconomy policy in September 2026 still has no replacement for Executive Order 14081, the September 2022 directive that organized federal biotechnology strategy, eighteen months after its revocation on March 14, 2025.
The University of Minnesota has quadrupled its biomanufacturing capability with a new facility on its St. Paul campus, per the university's August 14, 2026 announcement.
Tandem Health, a Stockholm-based digital health company building an AI medical assistant for clinical documentation, has raised $100 million in Series B funding led by the Scaleup Europe Fund, managed by EQT, the company announced on September 14, 2026.
SOPHiA GENETICS (NASDAQ: SOPH) and AstraZeneca (LSE/STO/NYSE: AZN) have signed a multi-year global collaboration, announced August 4, 2026, to develop, validate, and deploy two companion diagnostics for AstraZeneca precision oncology therapies, per the companies' announcement.